ADC and Radiopharmaceuticals Pharma and Biotech Partnering Summit

Topics

• Bringing clarity to the deal frenzy: clinical progress & capital invested in the last 12 months
• Strategic priorities & deal trends for future collaborations & investment in adc & radioligands
• Conjugation & click release chemistry: stability, solubility & tumor specificity
• Radiopharmaceuticals & novel antibody formats: marrying novel adc formats with radioisotypes to improve tumor selectivity & create exciting therapeutic potential
• Revisiting & discovering new target opportunities to expand adc & radioligand delivery
• What’s the next payload? developing a differentiated adc for future first-in-line therapeutic options
• Creative partnerships & deal processes: how to differentiate in the buy/sell dynamic